Rare diseases
Investigational molecules
Locations
117 Avenue De Luminy, 13009 Marseille, France
Innate Pharma’s clinical portfolio includes research in advanced solid tumours, with a particular focus on non-small cell lung cancer and perioperative treatment strategies in lung cancer.
The sponsor’s studies in this area reflect interest in tumour control around surgery and in treatment approaches for advanced disease.
Innate Pharma runs clinical trials in conditions such as Non-small cell lung cancer stage III, Non-small cell lung cancer stage II, Non-Hodgkin's lymphoma refractory, Cutaneous T-cell lymphoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFrance
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
